E
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 11 Jun 2025)
What this means for you
Registered since 11 Feb 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Feb 2030: the §8 & §9 renewal).
Record
- Serial number
- 88388296
- Registration number
- 5986237
- Mark type
- Design + words
- Filed
- 16 Apr 2019
- Published for opposition
- 13 Aug 2019
- Registered
- 11 Feb 2020
- Next maintenance filing
- §8 & §9 renewal, due by 11 Feb 2030 (grace period to 11 Aug 2030)
- Attorney of record
- Camille M. Miller
Goods and services
- Class 005 — Pharmaceuticals: drug substances, namely, enzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care [ ; nutritional and dietary supplements; vitamins and mineral supplements; food supplements ]
Owner
- ENDO OPERATIONS LIMITED, BALLSBRIDGE, IE
- Endo Pharmaceuticals Inc., Malvern, PA, US
- Endo Pharmaceuticals Inc., Malvern, PA, US
- Endo Pharmaceuticals Inc., Malvern, PA, US
Prior registrations
Prosecution history
- 11 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 11 Jun 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 11 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Feb 2025 — TEAS SECTION 8 & 15 RECEIVED
- 11 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Jun 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 01 May 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Dec 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Jun 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 11 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 09 Jan 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jan 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Nov 2019 — USE AMENDMENT FILED
- 29 Nov 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL